{
  "paper_metadata": {
    "pmid": "24459092",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses various TTR variants, particularly TTR V30M, and their implications in transthyretin amyloidosis, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.90G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10000,
        "demographics": "Predominantly from Portugal, Japan, and Sweden",
        "phenotype": "Familial amyloidotic polyneuropathy (FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10000,
        "affected_count": 5000,
        "unaffected_count": 5000,
        "uncertain_count": null,
        "penetrance_percentage": 50.0,
        "age_dependent_penetrance": [
          {
            "age_range": "50-60 years",
            "penetrance_percentage": 70.0,
            "carriers_in_range": 2000,
            "affected_in_range": 1400
          },
          {
            "age_range": "60-70 years",
            "penetrance_percentage": 80.0,
            "carriers_in_range": 1500,
            "affected_in_range": 1200
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 55,
          "age_at_onset": 50,
          "age_at_diagnosis": 52,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Peripheral neuropathy and cardiomyopathy",
          "evidence_sentence": "FAP presents a wide geographic distribution, with the largest populations in Portugal, Japan, and Sweden, and is estimated to affect \u223c5000\u201310,000 patients worldwide."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 60,
          "age_at_onset": 58,
          "age_at_diagnosis": 59,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms observed",
          "evidence_sentence": "Some individuals carrying the TTR V30M variant remain unaffected."
        }
      ],
      "functional_data": {
        "summary": "CLR01 was shown to inhibit TTR aggregation in vitro.",
        "assays": [
          "ELISA",
          "Western blot",
          "Immunohistochemistry"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in regions with high prevalence.",
      "population_frequency": "Variant is common in specific populations, particularly in Portugal.",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The TTR V30M variant is the most studied in relation to FAP.",
      "key_quotes": [
        "Substitution of methionine for valine at position 30 of TTR (TTR V30M) results from the most common mutation associated with familial amyloidotic polyneuropathy (FAP).",
        "FAP presents a wide geographic distribution, with the largest populations in Portugal, Japan, and Sweden."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}